LABU

Direxion Daily S&P Biotech Bull 3X Shares [LABU] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

LABU Stock Summary

Top LABU Correlated Resources

LABU

Top 10 Correlated ETFs

LABU

Top 10 Correlated Stocks

LABU

In the News

LABU Financial details

Company Rating
-
Market Cap
1.14B
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
0.07
Dividend %
0.16%
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-13.48%
SMA50
-17.2%
SMA100
-38.4%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
48.4-176.99
52W High
-54.6%
52W Low
+66.46%
RSI
46
Rel Volume
0.19
Avg Volume
2.96M
Volume
561.85K
Perf Week
3.91%
Perf Month
-9.2%
Perf Quarter
-37.94%
Perf Half Y
-43.03%
-
-
-
-
Beta
2.46
-
-
Volatility
2.07%, 6.35%
Prev Close
4.59%
Price
79.9
Change
8.1%

LABU Financial Performance

LABU Dividend History

LABU Frequently Asked Questions

What is Direxion Daily S&P Biotech Bull 3X Shares stock symbol ?

Direxion Daily S&P Biotech Bull 3X Shares is a US stock and trading under the symbol LABU

What is Direxion Daily S&P Biotech Bull 3X Shares stock quote today ?

Direxion Daily S&P Biotech Bull 3X Shares stock price is $79.9 today.

Is Direxion Daily S&P Biotech Bull 3X Shares stock public?

Yes, Direxion Daily S&P Biotech Bull 3X Shares is a publicly traded company.

Something similar

Top by Market Cap
LLY.DE
EMBASSY.NS
TSLA
0YXG.L
AAPL
Top Correlated ETFs
XBI
QCLN
BBC
CNCR
SBIO
Top Correlated Stocks
RCKT
GSIT
KLIC
IMMR
MYGN
Similar Market Cap
IONQ
DFPH
PAG.L
AWF
1881.HK

Company Profile

Financial Services Asset Management
  • Volume Average 2.96M
  • Market Capitalization 1.14B
  • Headquarters US
  • IPO Date 2015-05-28

The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments and securities of the index, exchange-traded funds ("ETFs") that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.